Evidence map›Paper›PMID 41566611›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Gravity-Tolerant In-Flight 3D Bioprinting Enabled by Stereolithography for Space Tissue Engineering.

Bianca Lemke, Matthias R Kollert, Tobias Lam, Tobias Thiele, Nicolas Göbel, Lisa R Köhn, Gabriela Korus, Lutz Kloke, Georg N Duda

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bianca LemkeJulius Wolff Institut, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0003-1211-8674
Matthias R KollertJulius Wolff Institut, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Tobias LamCellbricks GmbH, Berlin, Germany.
Tobias ThieleJulius Wolff Institut, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Nicolas GöbelJulius Wolff Institut, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Lisa R KöhnJulius Wolff Institut, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Gabriela KorusJulius Wolff Institut, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Lutz KlokeCellbricks GmbH, Berlin, Germany.
Georg N DudaJulius Wolff Institut, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0001-7605-3908

Funding

European Research Council 101054501European Research Council ERC-2021-ADGGerman Space Agency at DLR 50WB2034German Space Agency at DLR 50WB2311
6 · The paper itself

Abstract

Growing efforts toward long-duration human space missions demand novel strategies for the treatment of acute injuries in extreme environments. Technologies for space applications must perform reliably even under environmental stressors rarely encountered on Earth, such as gravitational fluctuations. However, space-compatible personalized therapy approaches for treatment of high-risk injuries remain scarce. 3D bioprinting represents an advanced technology with promising potential to address this unmet medical need by enabling the on-demand fabrication of patient-specific tissue constructs for regenerative wound care. Here, the robust 3D printing of both acellular and cell-laden hydrogel constructs is demonstrated using photo- and bioinks under diverse environmental conditions, including microgravity and hypergravity phases encountered during parabolic flight (0-1.8 g). Despite dynamic accelerative conditions, the developed flight-compliant, closed stereolithographic (SLA) bioprinting system successfully printed 3D structures with maintained dimensional fidelity. Irrespective of gravitational forces, high cell viability was preserved in both fibroblast- and keratinocyte-laden constructs. High-resolution features are achieved with precision comparable to normal-gravity controls. Complex architectures, including gyroids, can be fabricated with smooth, continuous surfaces. These findings establish SLA bioprinting as a robust and gravity-tolerant platform for fabricating viable, cell-laden constructs-offering a promising pathway for advancing tissue engineering in space and in extreme conditions on Earth.

Indexed as

BioprintingPrinting, Three-DimensionalSpace FlightStereolithographyTissue EngineeringGravitationHumansTissue ScaffoldsWeightlessnessbiofabricationin‐space manufacturingmicrogravityparabolic flighttissue engineering

Identifiers

PMID41566611
PMCPMC13042947

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.